Estás usando un navegador no soportado
Usar Internet Explorer está desaconsejado por problemas de seguridad. Para ver correctamente esta web, por favor use cualquier navegador moderno: Chrome, Firefox, Edge, Safari u otro de su elección.
En este apartado encontrará una actualización mensual de Trastornos del Movimiento
FILTRAR POR:
Por tema
5195 ARTÍCULOS , VIENDO DEL 1441 AL 1455
The efficacy of scopolamine for patients with Parkinson's disease and depression: Two case reports
Wang S, Guo P, Feng M, Qian M, Shen X, Wang G.
Asian J Psychiatr. 2020 Aug;52:102107. doi: 10.1016/j.ajp.2020.102107. Epub 2020 May 21.
Overview of Therapeutic Drugs and Methods for the Treatment of Parkinson's Disease
Schneider A, Sari AT, Alhaddad H, Sari Y.
CNS Neurol Disord Drug Targets. 2020;19(3):195-206. doi: 10.2174/1871527319666200525011110.
Emerging 5-HT receptor antagonists for the treatment of Schizophrenia
Jones MT, Strassnig MT, Harvey PD.
Expert Opin Emerg Drugs. 2020 Jun;25(2):189-200. doi: 10.1080/14728214.2020.1773792. Epub 2020 Jun 8.
Effects of COVID-19 on Parkinson's Disease Clinical Features: A Community-Based Case-Control Study
Cilia R, Bonvegna S, Straccia G, Andreasi NG, Elia AE, Romito LM, Devigili G, Cereda E, Eleopra R.
Mov Disord. 2020 Aug;35(8):1287-1292. doi: 10.1002/mds.28170. Epub 2020 Jun 11.
Should We Consider Deep Brain Stimulation Discontinuation in Late-Stage Parkinson's Disease?
Fabbri M, Zibetti M, Rizzone MG, Giannini G, Borellini L, Stefani A, Bove F, Bruno A, Calandra-Buonaura G, Modugno N, Piano C, Peppe A, Ardolino G, Romagnolo A, Artusi CA, Berchialla P, Montanaro E, Cortelli P, Luigi R, Eleopra R, Minafra B, Pacchetti C, Tufo T, Cogiamanian F, Lopiano L.
Mov Disord. 2020 Aug;35(8):1379-1387. doi: 10.1002/mds.28091. Epub 2020 May 25.
More than 20 years of the discovery of Park2
Mizuno Y.
Neurosci Res. 2020 Oct;159:3-8. doi: 10.1016/j.neures.2020.02.002. Epub 2020 May 23.
Nicotinamide riboside-A missing piece in the puzzle of exercise therapy for older adults?
Custodero C, Saini SK, Shin MJ, Jeon YK, Christou DD, McDermott MM, Leeuwenburgh C, Anton SD, Mankowski RT.
Exp Gerontol. 2020 Aug;137:110972. doi: 10.1016/j.exger.2020.110972. Epub 2020 May 22.
Ihle J, Artaud F, Bekadar S, Mangone G, Sambin S, Mariani LL, Bertrand H, Rascol O, Durif F, Derkinderen P, Scherzer C, Elbaz A, Corvol JC; DIGPD study group; Steering committee; Statistical analyses; Principal investigators for sites; Co-investigators (alphabetical order); Neuropsychologists; Genetic core; Sponsor activities and clinical research assistants.
Parkinsonism Relat Disord. 2020 Jun;75:30-33. doi: 10.1016/j.parkreldis.2020.03.017. Epub 2020 May 1.
The preclinical discovery and development of opicapone for the treatment of Parkinson's disease
Ettcheto M, Busquets O, Sánchez-Lopez E, Cano A, Manzine PR, Verdaguer E, Olloquequi J, Auladell C, Folch J, Camins A.
Expert Opin Drug Discov. 2020 Sep;15(9):993-1004. doi: 10.1080/17460441.2020.1767580. Epub 2020 May 26.
Stress and cortisol in Parkinson's disease
van Wamelen DJ, Wan YM, Ray Chaudhuri K, Jenner P.
Int Rev Neurobiol. 2020;152:131-156. doi: 10.1016/bs.irn.2020.01.005. Epub 2020 Feb 19.
The Role of Sphenobasilar Synchondrosis in Disease and Health
Liem T.
J Am Osteopath Assoc. 2020 Jun 1;120(6):404-412. doi: 10.7556/jaoa.2020.062.
Regulation of Iron Homeostasis and Related Diseases
Li Y, Huang X, Wang J, Huang R, Wan D.
Mediators Inflamm. 2020 May 2;2020:6062094. doi: 10.1155/2020/6062094. eCollection 2020.
The ubiquitous role of mitochondria in Parkinson and other neurodegenerative diseases
Theocharopoulou G.
AIMS Neurosci. 2020 Mar 25;7(1):43-65. doi: 10.3934/Neuroscience.2020004. eCollection 2020.
McCarty MF, Lerner A.
Int J Mol Sci. 2020 May 21;21(10):3624. doi: 10.3390/ijms21103624.
Anti-aggregation Effects of Phenolic Compounds on α-synuclein
Ono K, Tsuji M, Yamasaki TR, Pasinetti GM.
Molecules. 2020 May 24;25(10):2444. doi: 10.3390/molecules25102444.
Actualización mensual Regístrese para recibir los avisos de actualización
Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.